Monitor for future disclosure of deal terms in Ingredion's 10-Q or 8-K filings. The acquisition is a small bolt-on to expand functional ingredients but lacks financial details to move the stock near-term.
Price Chart
Executive Summary
Ingredion acquired Benicaros, a patented prebiotic carrot fiber with clinical immune-health data, in an asset deal including all IP and manufacturing know-how. The acquisition expands Ingredion's functional ingredients portfolio with a differentiated, upcycled product that addresses formulation challenges of traditional prebiotics. Deal value was not disclosed, limiting immediate financial impact assessment.
Key Facts
- Acquired Benicaros, a patented prebiotic fiber from upcycled carrot pomace with clinical immune-health benefits
- Asset deal includes full ownership of IP, trademarks, clinical trials, and manufacturing know-how
- Benicaros is water-soluble, low-dosage, plant-based, clean-label, kosher, halal, gluten-free, and upcycled
- Ingredion had 2025 annual net sales of approximately $7.2 billion
- Deal value was not disclosed in the press release
Financial Impact
Deal value undisclosed; likely immaterial relative to Ingredion's $7.2B annual sales and $6.4B market cap
Risk Factors
- Undisclosed deal value could be larger than implied, but likely small relative to Ingredion's scale
- Integration risk and commercial adoption of a novel prebiotic ingredient may take time
- No revenue or earnings guidance provided for the acquired asset
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304942 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $101.74 $104.74 | ▲ +2.95% | ▼ −2.07% | $95.33 (−6.30%) |
Jun 30, 2026 13w ago | Press Release | $94.71 $101.45 | ▲ +7.12% | ▲ +8.14% | $95.33 (+0.65%) |
Jun 30, 2026 13w ago | 8-K | $94.71 $101.45 | ▲ +7.12% | ▲ +8.14% | $95.33 (+0.65%) |
Jun 25, 2026 14w ago | 8-K | $97.50 $100.25 | ▲ +2.82% | ▲ +1.56% | $95.33 (−2.23%) |
Jun 9, 2026 16w ago | 8-K | $102.54 $97.49 | ▼ −4.92% | ▼ −8.55% | $95.33 (−7.03%) |
Jun 8, 2026 16w ago | Press Release | $99.66 $99.29 | ▼ −0.37% | ▼ −2.00% | $95.33 (−4.34%) |
Jun 2, 2026 17w ago | Press Release | $101.12 $95.62 | ▼ −5.44% | ▼ −3.87% | $95.33 (−5.73%) |
May 28, 2026 18w ago | Press Release | $103.21 $97.50 | ▼ −5.53% | ▼ −2.39% | $95.33 (−7.63%) |
May 20, 2026 19w ago | Press Release | $102.15 $97.91 | ▼ −4.15% | ▼ −4.48% | $95.33 (−6.68%) |
May 14, 2026 20w ago | 8-K | $102.25 $101.59 | ▼ −0.65% | ▲ +0.21% | $95.33 (−6.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access